PUMA gene inhibits the growth of PC-3 Pancreatic carcinoma cells

Ke-jun ZHANG,De-chun LI,Xin-guo ZHU,Dong-ming ZHU,Zhi-hong ZHAO

DOI: https://doi.org/10.3760/cma.j.issn.1674-1935.2006.06.010

2006-01-01

Abstract:Objective To investigate the antitumor effect of PUMA gene transfection into pancreatic cancer cell line PC-3. Methods Plasmid PUMA-pEGFP-C1 was introduced into pancreatic cancer cell line PC-3 by LipofectinamineTm 2000 transfection. Positive clones were screened by G418 and stable expression of PUMA was detected by Western blot and RT-PCR method. FCG was performed to test the rate of apoptosis. Fifteen athymic mice were equally randomized into 3 groups: the experiment group xenografted with PUMA expressing cells, the empty vector control group, and the control group. Weight of the mice and size of the tumors were measured every week.Eight weeks later the mice were killed and the tumors were removed. The tumor volume and weight were compared between the three groups. Western blot method was used to determine the expression of PUMA genes. Results The expression of PUMA in stable transfection PC-3 cells was detected. The rate of apoptosis by FCG was significantly higher in the experimental group (5.50 ± 0.90%) compared with the empty vector control group (1.073 ± 0.248%) and the control group (1.08 ± 0.35%). There was no significant difference in tumorigenicity between PC-3/PUMA and PC-3 cells (70% vs 100%), though the tumor volume generated by PC-3/PUMA cells was significantly smaller(P < 0.05). There was no significant difference in all the indicators between the empty vector control group and the control group (both P > 0.05). The expression of PUMA protein in the experimental group was higher than that in the empty vector control group and control group. Conclusions Re-expression of PUMA gene, the expression of which is lost in human pancreatic adenocarcinoma, induces apoptosis, thus inhibiting tumor growth.